No Data
No Data
Emerging market outlook: Will the Growth Market 250 Index take a break and individual stock picking strengthen with positive investor sentiment?
■ The emerging market this week has seen a significant increase in overall market conditions, with major stocks showing strength. During the same period, while the Nikkei Average increased by +0.79%, the Growth Market Index rose by +4.63% and the Growth Market 250 Index rose by +5.16%, highlighting the growth of the emerging market. Similar to the main board, trading volume has not expanded significantly, but driven by improved investor sentiment, major stocks with large market capitalization, such as constituents of the Growth Market Core Index, have shown overall strength. The Growth Market 250 Index opened on August 1st.
Part 2 of the previous day's moving stocks include M&A SOKO Holdings, Sakura Internet, Big Camera, etc.
Stock name (code) 20-day closing price ⇒ Previous day comparison Kitagawa Seiki <6327> 723-48. June 2015 operating profit is expected to decrease by 38%. MonotaRO <3064> 2,458.5-7. Sell off profits against the recent rise continues. Neo Marketing <4196> 1107 +20 Release a beta version of the new interview service "Chat AI Research DEMO!" that takes advantage of the latest AI technology. M&A Consulting Holdings <9552> 2785
Shin Bio Pharmaceutical initiates international collaborative phase 1b clinical trial targeting patients with malignant lymphoma with injection Brincidofovir.
On the 19th, Shionogi Pharmaceutical Co., Ltd. <4582> announced that it has submitted a clinical trial plan to the Pharmaceuticals and Medical Devices Agency on August 5, 2024 for an injection drug, Brincidofovir (IV BCV), for relapsed or refractory lymphoma patients (malignant lymphoma such as NK/T-cell lymphoma), and has started the Phase 1b/2 international clinical trial. The company has been conducting joint research on BCV with the Singapore National Cancer Centre, and in non-clinical trials of BCV...
Recommended stocks based on volume changes, including Seven Bank and others.
Stock Closing Price Change from Previous Day Volume*<2639> GX Bio & Med Day Stock 1672 1 6421*<8410> Seven Bank 288.9 22.1 39716200*<4582> Shionogi Pharma 320 80 20844500*<2841> IF NASDAQ 100 H Share 12650 495 95137
Stocks that moved the previous day, part 1: 7&iHD, Shionogi & Co., Ltd., Double A, etc.
Stock name <code>19 closing price ⇒ comparison with the previous dayAsuka Pharmaceutical HD <4886> 2,309 + 21 Obtained approval for manufacturing and selling oral contraceptive drospirenone in South Korea. In the afternoon, the increase narrowed. 7&iHD <3382> 2,161 + 400 Acquired proposal reported from Canada's largest convenience store chain, Alimentation Couche-Tard. Renascience <4889> 353 + 14 Clinical performance tests of AI to predict insulin dosage for diabetes patients have started. Economic <3802>
The Tokyo Stock Exchange Growth Market Index has risen for 9 consecutive days, showing relative stability.
Tokyo Stock Exchange Growth Market Index 786.35 +2.40 / volume 0.3533 billion shares / trading value 139 billion yen Tokyo Stock Exchange Growth Market 250 Index 612.03 +2.92 /volume 0.2502 billion shares / trading value 111.4 billion yen Today's growth market, the Tokyo Stock Exchange Growth Market Index has risen for 9 consecutive days, and the Tokyo Stock Exchange Growth Market 250 Index has also risen. The number of rising stocks is 206, the number of falling stocks is 348, and unchanged is 34. On the 16th, the Dow Jones Industrial Average rose 96.70 dollars to 40659.
No Data
No Data